We know that Sofdra is the first and only effective treatment approved for the treatment of AHH; with the. brilliant patient experience program and subsiquent commercial launch, I would think most dematologists would perscibing Sofdra as first choice. We have to be looking at easily more than 10% penetration very quickly.
IM optomistic O.
We know that Sofdra is the first and only effective treatment...
-
- There are more pages in this discussion • 1,365 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.010(2.41%) |
Mkt cap ! $770.9M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 43.0¢ | 41.5¢ | $2.549M | 6.044M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3910 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 69754 | 2 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |